Related references
Note: Only part of the references are listed.Fibroblast Growth Factor Receptors: From the Oncogenic Pathway to Targeted Therapy
S. Saichaemchan et al.
CURRENT MOLECULAR MEDICINE (2016)
The-553 T/A polymorphism in the promoter region of the FGF2 gene is associated with increased breast cancer risk in Polish women
Jan Rykala et al.
ARCHIVES OF MEDICAL SCIENCE (2015)
The role of HGF/MET and FGF/FGFR in fibroblast-derived growth stimulation and lapatinib-resistance of esophageal squamous cell carcinoma
Shin Saito et al.
BMC CANCER (2015)
The broad-spectrum anti-DNA virus agent cidofovir inhibits lung metastasis of virus-independent, FGF2-driven tumors
Sandra Liekens et al.
ONCOTARGET (2015)
Blockade of the Ras/MEK/ERK and Ras/PI3K/Akt pathways by statins reduces the expression of bFGF, HGF, and TGF-β as angiogenic factors in mouse osteosarcoma
Masanobu Tsubaki et al.
CYTOKINE (2011)
bFGF-mediated redox activation of the PI3K/Akt pathway in retinal photoreceptor cells
Stephen M. J. Farrell et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2011)
Fibroblast Growth Factor-2 Stimulates Directed Migration of Periodontal Ligament Cells via PI3K/AKT Signaling and CD44/Hyaluronan Interaction
Yoshio Shimabukuro et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2011)
Adenovirus-mediated transfer of siRNA against basic fibroblast growth factor mRNA enhances the sensitivity of glioblastoma cells to chemotherapy
Xuequan Feng et al.
MEDICAL ONCOLOGY (2011)
Mechanism of antitumor effect of a novel bFGF binding peptide on human colon cancer cells
Cong Wang et al.
CANCER SCIENCE (2010)
Fibroblast growth factor 2-induced cytoplasmic asparaginyl-tRNA synthetase promotes survival of osteoblasts by regulating anti-apoptotic PI3K/Akt signaling
Su Jin Park et al.
BONE (2009)
Fibroblast growth factor 2 restrains ras-driven proliferation of malignant cells by triggering RhoA-mediated senescence
Erico T. Costa et al.
CANCER RESEARCH (2008)
Pancreatic cancer cells overexpress gelsolin family-capping proteins, which contribute to their cell motility
C. C. Thompson et al.
GUT (2007)
Basic fibroblast growth factor (FGF-2) overexpression is a risk factor for esophageal cancer recurrence and reduced survival, which is ameliorated by coexpression of the FGF-2 antisense gene
C Barclay et al.
CLINICAL CANCER RESEARCH (2005)
Regulation of fibroblast growth factor-2 activity by human ovarian cancer tumor endothelium
MK Whitworth et al.
CLINICAL CANCER RESEARCH (2005)
Clinicopathological significance of heparanase and basic fibroblast growth factor expression in human esophageal cancer
Biao Han et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
FGF2 inhibits proliferation and alters the cartilage-like phenotype of RCS cells
P Krejci et al.
EXPERIMENTAL CELL RESEARCH (2004)
Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy
F Chang et al.
LEUKEMIA (2003)
Vascular endothelial growth growth factor and basic fibroblast growth factor expression in esophageal adenocarcinoma and Barrett esophagus
RVN Lord et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2003)
Fibroblast growth factor inhibits chondrocytic growth through induction of p21 and subsequent inactivation of cyclin E-Cdk2
T Aikawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
A novel isoform of human fibroblast growth factor 8 is induced by androgens and associated with progression of esophageal carcinoma
S Tanaka et al.
DIGESTIVE DISEASES AND SCIENCES (2001)
Share Paper
